{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:50:46Z","timestamp":1771491046931,"version":"3.50.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>During the mpox outbreak in 2022-2023, inequities in vaccine access and uptake were highlighted in several countries. We present an intersectionality-informed, equity-focused approach to understand how the intersection of several characteristics, practices, and circumstances created unique and specific barriers to accessing the mpox vaccine in the UK.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The study was co-produced with community co-researchers. Between April and July 2023, semi-structured in-depth interviews and focus group discussions were conducted online with 35 UK-based people of diverse ethnicity, sexual identity and orientation with risk factors for mpox. Interviews and focus groups were audio-recorded and transcribed. Transcripts and codes were analysed applying an equity lens focused on understanding how the intersection of demographics, practices and circumstances might lead to exclusion from the mpox vaccination public health campaign. Combining data from all participants, we designed four composite fictional\n                      <jats:italic>personas<\/jats:italic>\n                      who correspond to representative profiles of people that found themselves at the margins of the UK mpox vaccination campaign.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The thirty-five participants were diverse in terms of gender (28 cisgender men, 7 transgender or non-binary) and ethnicity (including White, Black, Asian, Latino\/x and Arab individuals). We identified six circumstances leading to the exclusion of the UK mpox vaccination campaign: i) not being connected to sexual health services or community organisations and advocates; ii) feeling that the vaccine criteria are too restrictive; iii) lacking trust in institution, often because of structural racism; iv) experiencing feasibility barriers; v) living outside of London; vi) being in a relationship with someone with more risk factors. Our four fictional personas combine these circumstances and represent the characteristics of someone on the margins, either geographically or socially.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings highlight the need to design more inclusive vaccine campaigns during evolving public health emergencies that consider how the intersection of stigma, characteristics, practices, and circumstances might lead to exclusion and inhibit vaccine uptake. Our persona approach further highlights the need to consider whether shared barriers to engagement (which can span multiple identities and positionalities) require tailored solutions. Guidelines should be co-designed with affected communities and include stigma-reduction interventions to ensure equitable provision and access to vaccine programmes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-025-24694-w","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:20:25Z","timestamp":1761898825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["\u2018It was something that I let slip by the wayside\u2019: a qualitative study of challenges to equitable mpox vaccination in the UK outbreak response"],"prefix":"10.1186","volume":"25","author":[{"given":"Chlo\u00e9","family":"Pasin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Weil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalie","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qaisar","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Will","family":"Nutland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismael","family":"Maatouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chloe M","family":"Orkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Paparini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"24694_CR1","doi-asserted-by":"publisher","first-page":"o1874","DOI":"10.1136\/bmj.o1874","volume":"378","author":"L Taylor","year":"2022","unstructured":"Taylor L. Monkeypox: WHO declares a public health emergency of international concern. BMJ. 2022;378:o1874.","journal-title":"BMJ"},{"issue":"10454","key":"24694_CR2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/S0140-6736(24)01751-3","volume":"404","author":"P Adepoju","year":"2024","unstructured":"Adepoju P. Mpox declared a public health emergency. Lancet. 2024;404(10454):e1\u20132.","journal-title":"Lancet"},{"key":"24694_CR3","doi-asserted-by":"crossref","unstructured":"Thornhill JP, Gandhi M, Orkin C, Mpox: The reemergence of an old disease and inequities. Annu Rev Med. 2024;75:159\u201375.","DOI":"10.1146\/annurev-med-080122-030714"},{"key":"24694_CR4","unstructured":"Strategic framework for enhancing prevention and control of Mpox 2024\u20132027. Geneva: World Health Organization; 2024."},{"key":"24694_CR5","unstructured":"First meeting of the International Health Regulations. Emergency Committee regarding the upsurge of mpox 2024. 2005. Available from: https:\/\/www.who.int\/news\/item\/19-08-2024-first-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-upsurge-of-mpox-2024."},{"key":"24694_CR6","unstructured":"Mpox outbreak: epidemiological overview. 2025. Available from: https:\/\/www.gov.uk\/government\/publications\/monkeypox-outbreak-epidemiological-overview\/mpox-outbreak-epidemiological-overview-9-january-2025."},{"issue":"10380","key":"24694_CR7","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(23)00273-8","volume":"401","author":"O Mitj\u00e0","year":"2023","unstructured":"Mitj\u00e0 O, Alemany A, Marks M, Lezama Mora JI, Rodr\u00edguez-Aldama JC, Torres Silva MS, et al. Mpox in people with advanced HIV infection: a global case series. Lancet. 2023;401(10380):939\u201349.","journal-title":"Lancet"},{"issue":"2","key":"24694_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2024-016937","volume":"10","author":"CLJ Ugwu","year":"2025","unstructured":"Ugwu CLJ, Bragazzi NL, Wu J, Kong JD, Asgary A, Orbinski J, et al. Risk factors associated with human Mpox infection: a systematic review and meta-analysis. BMJ Glob Health. 2025;10(2):e016937.","journal-title":"BMJ Glob Health"},{"key":"24694_CR9","unstructured":"World Health Organization. Mpox 2024. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/mpox."},{"key":"24694_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.12688\/wellcomeopenres.18436.2","volume":"7","author":"J Garcia Iglesias","year":"2023","unstructured":"Garcia Iglesias J, Nagington M, Pickersgill M, Brady M, Dewsnap C, Highleyman L, et al. Is Mpox an STI? The societal aspects and healthcare implications of a key question [version 2; peer review: 2 approved]. Wellcome Open Res. 2023;7:252.","journal-title":"Wellcome Open Res"},{"key":"24694_CR11","unstructured":"UK strategy for mpox control, 2022 to 2023. Published 8 December 2022. Available from: https:\/\/www.gov.uk\/government\/publications\/mpox-monkeypox-control-uk-strategy-2022-to-2023\/uk-strategy-for-mpox-control-2022-to-2023#public-health-interventions-to-meet-our-aims."},{"key":"24694_CR12","unstructured":"JCVI statement on mpox vaccination as a routine programme. 2023. Available from: https:\/\/www.gov.uk\/government\/publications\/mpox-vaccination-programme-jcvi-advice-10-november\/jcvi-statement-on-mpox-vaccination-as-a-routine-programme."},{"key":"24694_CR13","unstructured":"Garcia Iglesias J, Williams J, McHugh CJ, Nagington M, May TW, Buijsen S, et al. Responding to mpox: communities, communication and infrastructures. University College London Press; 2023."},{"issue":"1","key":"24694_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-19176-4","volume":"24","author":"CP Biesty","year":"2024","unstructured":"Biesty CP, Hemingway C, Woolgar J, Taylor K, Lawton MD, Waheed MW, et al. Community led health promotion to counter stigma and increase trust amongst priority populations: lessons from the 2022\u20132023 UK Mpox outbreak. BMC Public Health. 2024;24(1):1638.","journal-title":"BMC Public Health"},{"issue":"1","key":"24694_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjph-2023-000407","volume":"1","author":"J Garcia-Iglesias","year":"2023","unstructured":"Garcia-Iglesias J, May T, Pickersgill M, Williams J, Nagington M, Buijsen S, et al. Social media as a public health tool during the UK Mpox outbreak: a qualitative study of stakeholders experiences. BMJ Public Health. 2023;1(1):e000407.","journal-title":"BMJ Public Health"},{"issue":"6","key":"24694_CR16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1177\/09564624231155995","volume":"34","author":"M Tweed","year":"2023","unstructured":"Tweed M, Fortescue-Talwar K, Finn R, Buonsenno L, Nichols K, Frem J, et al. Delivering a community-based Monkeypox vaccination programme in partnership. Int J STD AIDS. 2023;34(6):427\u20139.","journal-title":"Int J STD AIDS"},{"key":"24694_CR17","doi-asserted-by":"publisher","unstructured":"Palumbo L, Picchio CA, Barbier F, Calderon-Cifuentes A, James J, Lunchenkov N, et al. Co-creating a Mpox elimination campaign in the WHO European region: the central role of affected communities. Open Forum Infect Dis. 2024;11(10). https:\/\/doi.org\/10.1093\/ofid\/ofae523.","DOI":"10.1093\/ofid\/ofae523"},{"issue":"5","key":"24694_CR18","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/hiv.13430","volume":"24","author":"S Paparini","year":"2023","unstructured":"Paparini S, Whitacre R, Smuk M, Thornhill J, Mwendera C, Strachan S, et al. Public understanding and awareness of and response to Monkeypox virus outbreak: a cross-sectional survey of the most affected communities in the United Kingdom during the 2022 public health emergency. HIV Med. 2023;24(5):544\u201357.","journal-title":"HIV Med"},{"key":"24694_CR19","doi-asserted-by":"crossref","unstructured":"Ogaz D, Enayat Q, Brown JR, Phillips D, Wilkie R, Jayes D, et al. Mpox diagnosis, behavioral risk modification, and vaccination uptake among gay, bisexual, and other men who have sex with men, United Kingdom, 2022. Emerg Infect Dis. 2024;30(5):916.","DOI":"10.3201\/eid3005.230676"},{"issue":"12","key":"24694_CR20","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1177\/09564624241273778","volume":"35","author":"G Baldry","year":"2024","unstructured":"Baldry G, Phillips D, Wilkie R, Checchi M, Folkard K, Simmons R, et al. Factors associated with human papillomavirus, hepatitis A, hepatitis B and Mpox vaccination uptake among gay, bisexual and other men who have sex with men in the UK\u2013 findings from the large community-based Riish-Mpox survey. Int J STD AIDS. 2024;35(12):963\u201381.","journal-title":"Int J STD AIDS"},{"key":"24694_CR21","doi-asserted-by":"publisher","unstructured":"Mullen D, Edney J, Phillips D, Wilkie R, Reid D, Lowndes CM, et al. Mpox vaccination uptake in a UK community sample of gay, bisexual and other men who have sex with men (GBMSM) the year following the 2022 clade IIb mpox outbreak. Sex Transm Infect. 2025;101:203\u20134. https:\/\/doi.org\/10.1136\/sextrans-2024-056358.","DOI":"10.1136\/sextrans-2024-056358"},{"issue":"2","key":"24694_CR22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.vaccine.2023.12.018","volume":"42","author":"VW Jongen","year":"2024","unstructured":"Jongen VW, Groot Bruinderink ML, Boyd A, Koole JCD, Teker B, Dukers-Muijrers NHTM, et al. What determines Mpox vaccination uptake? Assessing the effect of intent-to-vaccinate versus other determinants among men who have sex with men. Vaccine. 2024;42(2):186\u201393.","journal-title":"Vaccine"},{"key":"24694_CR23","doi-asserted-by":"crossref","unstructured":"Dukers-Muijrers NHTM, Evers Y, Widdershoven V, Davidovich U, Adam PCG, Op de Coul ELM et al. Mpox vaccination willingness, determinants, and communication needs in gay, bisexual, and other men who have sex with men, in the context of limited vaccine availability in the Netherlands (Dutch Mpox-survey). Front Public Health. 2023;10.","DOI":"10.3389\/fpubh.2022.1058807"},{"issue":"5","key":"24694_CR24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1071\/SH23047","volume":"20","author":"J MacGibbon","year":"2023","unstructured":"MacGibbon J, Cornelisse VJ, Smith AKJ, Broady TR, Hammoud MA, Bavinton BR, et al. Mpox (monkeypox) knowledge, concern, willingness to change behaviour, and seek vaccination: results of a national cross-sectional survey. Sex Health. 2023;20(5):403\u201310.","journal-title":"Sex Health"},{"issue":"1","key":"24694_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-19260-9","volume":"24","author":"J Liu","year":"2024","unstructured":"Liu J, Liu S, Yu S, Du X, Hao J, Hui R, et al. Willingness to receive Mpox vaccine among men who have sex with men: a systematic review and meta-analysis. BMC Public Health. 2024;24(1):1878.","journal-title":"BMC Public Health"},{"issue":"42","key":"24694_CR26","doi-asserted-by":"publisher","first-page":"2200757","DOI":"10.2807\/1560-7917.ES.2022.27.42.2200757","volume":"27","author":"J apos Reyes-Urue\u00f1a","year":"2022","unstructured":"apos Reyes-Urue\u00f1a J, Ambrosio A, Croci R, Bluemel B, Cenciarelli O, et al. High Monkeypox vaccine acceptance among male users of smartphone-based online gay-dating apps in europe, 30 July to 12 August 2022. Eurosurveillance. 2022;27(42):2200757.","journal-title":"Eurosurveillance"},{"issue":"1","key":"24694_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-024-00564-1","volume":"4","author":"SK Sulaiman","year":"2024","unstructured":"Sulaiman SK, Isma\u2019il Tsiga-Ahmed F, Musa MS, Makama BT, Sulaiman AK, Abdulaziz TB. Global prevalence and correlates of Mpox vaccine acceptance and uptake: a systematic review and meta-analysis. Commun Med. 2024;4(1):136.","journal-title":"Commun Med"},{"issue":"10","key":"24694_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-070882","volume":"13","author":"LE Smith","year":"2023","unstructured":"Smith LE, Potts HW, Brainard J, May T, Oliver I, Aml\u00f4t R, et al. Did mpox knowledge, attitudes and beliefs affect intended behaviour in the general population and men who are gay, bisexual and who have sex with men? An online cross-sectional survey in the UK. BMJ Open. 2023;13(10):e070882.","journal-title":"BMJ Open"},{"issue":"27","key":"24694_CR29","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1016\/j.vaccine.2023.05.043","volume":"41","author":"MG Curtis","year":"2023","unstructured":"Curtis MG, Davoudpour S, Rodriguez-Ortiz AE, Felt D, French AL, Hosek SG, et al. Predictors of Mpox vaccine uptake among sexual and gender minority young adults living in Illinois: unvaccinated vs. double vs. single dose vaccine recipients. Vaccine. 2023;41(27):4002\u20138.","journal-title":"Vaccine"},{"issue":"11","key":"24694_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0313325","volume":"19","author":"J Gilmore","year":"2024","unstructured":"Gilmore J, Comer D, Field DJ, Parlour R, Shanley A, Noone C. Recognising and responding to the community needs of gay and bisexual men around Mpox. PLoS ONE. 2024;19(11):e0313325.","journal-title":"PLoS ONE"},{"issue":"15","key":"24694_CR31","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1016\/j.vaccine.2023.02.075","volume":"41","author":"M Gilbert","year":"2023","unstructured":"Gilbert M, Ablona A, Chang H-J, Grennan T, Irvine MA, Sarai Racey C, et al. Uptake of Mpox vaccination among transgender people and gay, bisexual and other men who have sex with men among sexually-transmitted infection clinic clients in vancouver, British Columbia. Vaccine. 2023;41(15):2485\u201394.","journal-title":"Vaccine"},{"issue":"2","key":"24694_CR32","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/jrh.12726","volume":"39","author":"C Owens","year":"2023","unstructured":"Owens C, Hubach RD. Rural-urban differences in Monkeypox behaviors and attitudes among men who have sex with men in the United States. J Rural Health. 2023;39(2):508\u201315.","journal-title":"J Rural Health"},{"key":"24694_CR33","doi-asserted-by":"crossref","unstructured":"Grov C, Zohra F, Mirzayi C, Stief M, D\u2019Angelo AB, Dearolf M, et al. Sexual and gender minorities\u2019 vaccine uptake and behavioral change in response to the Mpox outbreak in the united states: August 2022 through November 2022. Clin Infect Dis. 2024.","DOI":"10.1093\/cid\/ciad793"},{"key":"24694_CR34","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1016\/S0140-6736(24)01999-8","volume":"404","author":"A Kamenshchikova","year":"2024","unstructured":"Kamenshchikova A, Deal A, Hargreaves S. Qualitative research on catch-up vaccination with Russian speaking migrants in the UK: potential opportunities beyond primary care. Lancet. 2024;404:S48.","journal-title":"Lancet"},{"issue":"1","key":"24694_CR35","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1186\/s12889-023-17196-0","volume":"23","author":"T May","year":"2023","unstructured":"May T, Towler L, Smith LE, Horwood J, Denford S, Rubin GJ, et al. Mpox knowledge, behaviours and barriers to public health measures among gay, bisexual and other men who have sex with men in the UK: a qualitative study to inform public health guidance and messaging. BMC Public Health. 2023;23(1):2265.","journal-title":"BMC Public Health"},{"issue":"1","key":"24694_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-19062-z","volume":"24","author":"BP Takenaka","year":"2024","unstructured":"Takenaka BP, Kirklewski SJ, Griffith FJ, Gibbs JJ, Lauckner CK, Nicholson E, et al. It\u2019s another gay disease: an intersectional qualitative approach contextualizing the lived experiences of young gay, bisexual, and other sexual minoritized men in the United States during the Mpox outbreak. BMC Public Health. 2024;24(1):1574.","journal-title":"BMC Public Health"},{"issue":"2","key":"24694_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1177\/15248399231215054","volume":"26","author":"H Agroia","year":"2025","unstructured":"Agroia H, Smith E, Vaidya A, Rudman S, Roy M. Monkeypox (Mpox) vaccine hesitancy among Mpox cases: a qualitative study. Health Promot Pract. 2025;26(2):315\u201324.","journal-title":"Health Promot Pract"},{"issue":"2","key":"24694_CR38","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1016\/S2352-3018(23)00302-8","volume":"11","author":"M Kohli","year":"2024","unstructured":"Kohli M, Reeves I, Waters L. Homophobia in the provision of sexual health care in the UK. Lancet HIV. 2024;11(2):e125\u201330.","journal-title":"Lancet HIV"},{"key":"24694_CR39","doi-asserted-by":"crossref","unstructured":"Cardoso Pinto A. Inequities in managing and representing Mpox. BMJ. 2023;380:537.","DOI":"10.1136\/bmj.p537"},{"issue":"4","key":"24694_CR40","doi-asserted-by":"publisher","first-page":"e237873","DOI":"10.1001\/jamanetworkopen.2023.7873","volume":"6","author":"PA Kahn","year":"2023","unstructured":"Kahn PA, Ying X, Virata M, Magahis P, Li S, Mathis WS. Availability and accessibility of live nonreplicating smallpox\/mpox vaccine. JAMA Netw Open. 2023;6(4):e237873-e.","journal-title":"JAMA Netw Open"},{"key":"24694_CR41","doi-asserted-by":"crossref","unstructured":"Karan A, Contag C, Barry M. Health inequities continue to drive the public health threat of Mpox. BMJ. 2023;381:1391.","DOI":"10.1136\/bmj.p1391"},{"issue":"1","key":"24694_CR42","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s11524-022-00712-9","volume":"100","author":"A Ogunbajo","year":"2023","unstructured":"Ogunbajo A, Euceda A, Smith J, Ekundayo R, Wattree J, Brooks M, et al. Demographics and health beliefs of black gay, bisexual, and other sexual minority men receiving a Mpox vaccination in the United States. J Urban Health. 2023;100(1):204\u201311.","journal-title":"J Urban Health"},{"key":"24694_CR43","doi-asserted-by":"publisher","first-page":"398","DOI":"10.15585\/mmwr.mm7215a4","volume":"72","author":"KK Kota","year":"2023","unstructured":"Kota KK, Hong J, Zelaya C, Riser AP, Rodriguez A, Weller DL, et al. Racial and ethnic disparities in Mpox cases and vaccination among adult males\u2014United states, may\u2013december 2022. MMWR Morb Mortal Wkly Rep. 2023;72:398\u2013403.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"24694_CR44","unstructured":"Crenshaw KW. Mapping the margins: intersectionality, identity politics, and violence against women of color. The public nature of private violence. Routledge; 2013. pp. 93\u2013118."},{"issue":"8","key":"24694_CR45","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/23744235.2024.2364801","volume":"56","author":"S Paparini","year":"2024","unstructured":"Paparini S, Isabelle W, Chikondi M, Rosalie H, Ismael M, Rosamund L, et al. Prevention of sexual transmission of mpox: a systematic review and qualitative evidence synthesis of approaches. Infect Dis. 2024;56(8):589\u2013605.","journal-title":"Infect Dis"},{"key":"24694_CR46","unstructured":"UK Health Security Agency. Mpox (monkeypox) outbreak: epidemiological overview, 3 August 2023. Updated 9 January 2025. Available from: https:\/\/webarchive.nationalarchives.gov.uk\/ukgwa\/20250128212719\/https:\/\/www.gov.uk\/government\/publications\/monkeypox-outbreak-epidemiological-overview\/mpox-monkeypox-outbreak-epidemiological-overview-3-august-2023."},{"key":"24694_CR47","unstructured":"Green J, Thorogood N. Qualitative methods for health research. 2018."},{"key":"24694_CR48","unstructured":"Krueger RA. Focus groups: A practical guide for applied research. Sage publications; 2014."},{"issue":"1","key":"24694_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-117","volume":"13","author":"NK Gale","year":"2013","unstructured":"Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13(1):117.","journal-title":"BMC Med Res Methodol"},{"issue":"741","key":"24694_CR50","doi-asserted-by":"publisher","first-page":"e250","DOI":"10.3399\/BJGP.2023.0412","volume":"74","author":"L Husain","year":"2024","unstructured":"Husain L, Finlay T, Husain A, Wherton J, Hughes G, Greenhalgh T. Developing user personas to capture intersecting dimensions of disadvantage in older patients who are marginalised: a qualitative study. Br J Gen Pract. 2024;74(741):e250\u20137.","journal-title":"Br J Gen Pract"},{"issue":"4","key":"24694_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0284710","volume":"18","author":"RL Knight","year":"2023","unstructured":"Knight RL, Mackintosh KA, Hudson J, Shelley J, Saynor ZL, McNarry MA. Battling the unknown: using composite vignettes to portray lived experiences of COVID-19 and long-COVID. PLoS ONE. 2023;18(4):e0284710.","journal-title":"PLoS ONE"},{"issue":"4","key":"24694_CR52","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/S40037-022-00723-X","volume":"11","author":"Z McElhinney","year":"2022","unstructured":"McElhinney Z, Kennedy C. Enhancing the collective, protecting the personal: the valuable role of composite narratives in medical education research. Perspect Med Educ. 2022;11(4):220\u20137.","journal-title":"Perspect Med Educ"},{"key":"24694_CR53","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.wsif.2013.01.007","volume":"37","author":"N Taber","year":"2013","unstructured":"Taber N. A composite life history of a mother in the military: storying gendered experiences. Women\u2019s Stud Int Forum. 2013;37:16\u201325.","journal-title":"Women\u2019s Stud Int Forum"},{"key":"24694_CR54","doi-asserted-by":"publisher","first-page":"E94","DOI":"10.5888\/pcd11.130402","volume":"11","author":"T Thompson","year":"2014","unstructured":"Thompson T, Kreuter MW. Using written narratives in public health practice: A creative writing perspective. Prev Chronic Dis. 2014;11:E94.","journal-title":"Prev Chronic Dis"},{"issue":"4","key":"24694_CR55","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/1468794118787711","volume":"19","author":"R Willis","year":"2019","unstructured":"Willis R. The use of composite narratives to present interview findings. Qual Res. 2019;19(4):471\u201380.","journal-title":"Qual Res"},{"key":"24694_CR56","unstructured":"UK Health Security Agency. Answering questions on monkeypox vaccination 2022. Available from: https:\/\/ukhsa.blog.gov.uk\/2022\/10\/28\/answering-questions-on-monkeypox-vaccination\/."},{"key":"24694_CR57","doi-asserted-by":"publisher","unstructured":"Witzel TC, Ghobrial A, Palich R, Charles H, Rodger AJ, Sabin C, et al. Experiences of Mpox illness and case management among cis and trans gay, bisexual and other men who have sex with men in England: a qualitative study. eClinicalMedicine. 2024;70. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102522.","DOI":"10.1016\/j.eclinm.2024.102522"},{"key":"24694_CR58","volume":"23","author":"JW M\u00e4rz","year":"2022","unstructured":"M\u00e4rz JW, Holm S, Biller-Andorno N. Monkeypox, stigma and public health. Lancet Reg Health. 2022;23:100536.","journal-title":"Lancet Reg Health"},{"key":"24694_CR59","doi-asserted-by":"crossref","unstructured":"Paterson A, Mughogho KK, Cheyne A, Kabajaasi O, Sarkar T, Dimitrios KH, et al. The (Re)-emerging and ePidemic infectious diseases (RAPID) stigma scales: a cross-outbreak scale development and pyschometric validation study. Lancet Infect Dis. 2025.","DOI":"10.1016\/S1473-3099(25)00161-6"},{"issue":"14","key":"24694_CR60","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1080\/10410236.2020.1838092","volume":"35","author":"H-J Paek","year":"2020","unstructured":"Paek H-J, Hove T. Communicating uncertainties during the COVID-19 outbreak. Health Commun. 2020;35(14):1729\u201331.","journal-title":"Health Commun"},{"issue":"4","key":"24694_CR61","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1088\/0963-6625\/11\/4\/304","volume":"11","author":"LJ Frewer","year":"2002","unstructured":"Frewer LJ, Miles S, Brennan M, Kuznesof S, Ness M, Ritson C. Public preferences for informed choice under conditions of risk uncertainty. Public Underst Sci. 2002;11(4):363\u201372.","journal-title":"Public Underst Sci"},{"key":"24694_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fcomm.2020.539174","volume":"5","author":"S Peinado","year":"2020","unstructured":"Peinado S, Treiman K, Uhrig JD, Taylor JC, Stryker JE. Effectively communicating about HIV and other health disparities: findings from a literature review and future directions. Front Commun. 2020;5:2020.","journal-title":"Front Commun"},{"key":"24694_CR63","unstructured":"NIHR Evidence. Promoting vaccination: the right approach for the right group. 2023."},{"key":"24694_CR64","unstructured":"JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea 2023. Available from: https:\/\/www.gov.uk\/government\/publications\/meningococcal-b-vaccination-for-the-prevention-of-gonorrhoea-jcvi-advice-10-november\/jcvi-advice-on-the-use-of-meningococcal-b-vaccination-for-the-prevention-of-gonorrhoea#references."},{"key":"24694_CR65","unstructured":"Finch D, Gazzillo A, Vriend M. Investing in the public health grant: what it is and why greater investment is needed. Health Foundation; 2024."},{"issue":"1","key":"24694_CR66","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-080250","volume":"14","author":"R Hayes","year":"2024","unstructured":"Hayes R, Dakin F, Smuk M, Paparini S, Apea V, Dewsnap C, et al. Cross-sectional survey of sexual health professionals\u2019 experiences and perceptions of the 2022 Mpox outbreak in the UK. BMJ Open. 2024;14(1):e080250.","journal-title":"BMJ Open"},{"key":"24694_CR67","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.r480","volume":"388","author":"K Arbuthnott","year":"2025","unstructured":"Arbuthnott K, Briggs A. Public health grant funding\u2014a welcome boost after a decade of neglect. BMJ. 2025;388:r480.","journal-title":"BMJ"},{"issue":"2","key":"24694_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0003704","volume":"5","author":"V Apea","year":"2025","unstructured":"Apea V, Titanji BK, Dakin FH, Hayes R, Smuk M, Kawu H, et al. International healthcare workers\u2019 experiences and perceptions of the 2022 multi-country Mpox outbreak. PLoS Glob Public Health. 2025;5(2):e0003704.","journal-title":"PLoS Glob Public Health"},{"issue":"3","key":"24694_CR69","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/1467-9566.13265","volume":"43","author":"NJ Fox","year":"2021","unstructured":"Fox NJ, Powell K. Non-human matter, health disparities and a thousand tiny dis\/advantages. Sociol Health Illn. 2021;43(3):779\u201395.","journal-title":"Sociol Health Illn"},{"key":"24694_CR70","unstructured":"World Health Organization. How to achieve and sustain high uptake of mpox vaccination in outbreak settings. 2025. Available from: https:\/\/www.who.int\/publications\/m\/item\/how-to-achieve-and-sustain-high-uptake-of-mpox-vaccination-in-outbreak-settings."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24694-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-24694-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24694-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:02:59Z","timestamp":1761901379000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-24694-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24694"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-24694-w","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"23 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for the study was obtained from the Queen Mary Ethics of Research Committee on 13 March 2023 (QMERC22.045). All participants received a participant information sheet and gave written and verbal informed consent to take part in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CMO has received honoraria for advisory boards, lectureships and travel sponsorships from Janssen, Gilead Sciences, ViiV Healthcare, MSD and Bavarian Nordic and has received research grants from Janssen, Gilead Sciences, ViiV Healthcare, MSD and AstraZeneca. SP has received research grants from Gilead Sciences and ViiV Healthcare. The remaining authors (CP, BW, RH, QS, IW, WN and IM) declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3678"}}